Skip to main content
. 2022 Feb 19;13(3):5962–5974. doi: 10.1080/21655979.2022.2036900

Figure 6.

Figure 6.

ZFAS1 promotes osteosarcoma progression in vivo through SRSF3.

(a) Images of xenografts tumors. (b) ZFAS1 expression in xenografts. (c) SRSF3 protein levels in xenografts. Actin was served as the loading control. (d and e) ZFAS1 knockdown reduced tumor volumes (D) and tumor sizes (E), but exogenous SRSF3 expression reversed these phenotypes.